Trial: 202006123

Phase Ib study of gevokizumab in combination with standard of care anti-cancer therapies in patients with metastatic colorectal cancer, gastroesophageal cancer and renal cell carcinoma

Phase

I

Principal Investigator

Pedersen, Katrina

Disease Site

Colon; Esophagus; Kidney; Rectum; Stomach

Learn more about this study at: clinicaltrials.gov